Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

Slični predmeti

• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  od: Hofmann, Susanne, i dr.
  Izdano: (2019)
• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  od: Susanne Hofmann, i dr.
  Izdano: (2019)
• Chimeric antigen receptor transduced T cells: Tuning up for the next generation
  od: Maria‐Luisa Schubert, i dr.
  Izdano: (2017)
• Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
  od: Korell, Felix, i dr.
  Izdano: (2021)
• Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies
  od: Wang, Sanmei, i dr.
  Izdano: (2021)